Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.
Rapidly rising obesity rates in the US threaten to reverse decades of effort against cardiometabolic disease. How well do you know what experts recommend for your at-risk patients?
Carl "Chip" Lavie, MD, author of the original book titled, "The Obesity Paradox" explains the paradox of metabolic health in the obese, how it wanes, and an essential element to maintain it.
For the first time, the USPSTF recommends colorectal cancer screening in adults beginning at age 45.
Waist circumference measures, complementary antihypertensives, appropriate exercise levels for T2D patients--test what you know about cardiometabolic risk and management.
Global confirmed cases of COVID-19 have surpassed 44 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.
New research shows nearly 30% of US young adults do not know the 5 most common stroke symptoms, almost 3 million are not aware of any symptoms.
Weight loss is essential to arrest the cardiovascular disease and metabolic dysfunction linked to obesity. What do you know about the drugs now available that may help?
How many cases of COVID-19 have been confirmed in the US? How many people have been tested? Get your daily COVID-19 update here.
Dapagliflozin is renoprotective and cardioprotective in chronic kidney disease patients, suggests a secondary analysis of the DAPA-CKD trial presented at Kidney Week 2020.